Physician profile
Tanya Mitchell
NPI 1366290595
$401.01
in general payments reported to CMS, 2019-2025
11 companies · $401 in 2025
The $401 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $401.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $401.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $108.49 | 2025 | Freestyle Libre 3 |
| Phathom Pharmaceuticals, INC. | $49.68 | 2025 | Voquezna |
| Coopersurgical, INC. | $45.88 | 2025 | Paragard T 380a |
| Hologic Sales and Service, LLC | $37.83 | 2025 | Omni Hysteroscope |
| Baxter Healthcare | $32.64 | 2025 | Perclot |
| Octapharma USA, INC. | $31.49 | 2025 | Fibryga |
| Vertex Pharmaceuticals Incorporated | $22.49 | 2025 | |
| Exeltis, USA INC. | $21.65 | 2025 | Slynd |
| Astellas Pharma US INC | $18.19 | 2025 | Veozah |
| Biogen, INC. | $16.93 | 2025 | Zurzuvae |
| Shield Therapeutics INC | $15.74 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tanya Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.